1. Home
  2. PDS vs TBPH Comparison

PDS vs TBPH Comparison

Compare PDS & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Drilling Corporation

PDS

Precision Drilling Corporation

HOLD

Current Price

$91.48

Market Cap

918.1M

Sector

N/A

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.68

Market Cap

824.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDS
TBPH
Founded
1951
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
918.1M
824.9M
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
PDS
TBPH
Price
$91.48
$16.68
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$122.33
$18.40
AVG Volume (30 Days)
96.9K
308.9K
Earning Date
04-29-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
279.13
EPS
N/A
N/A
Revenue
N/A
$15,386,000.00
Revenue This Year
$5.66
$8.46
Revenue Next Year
$2.31
N/A
P/E Ratio
$884.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$41.95
$8.33
52 Week High
$103.80
$21.03

Technical Indicators

Market Signals
Indicator
PDS
TBPH
Relative Strength Index (RSI) 48.78 50.81
Support Level $83.72 $16.14
Resistance Level $92.40 $17.24
Average True Range (ATR) 3.14 0.39
MACD -0.42 -0.02
Stochastic Oscillator 31.51 46.86

Price Performance

Historical Comparison
PDS
TBPH

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: